Ibrance 125 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F0XV5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,555
Award facts
- Contract value 100% obligated
- $8,555.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,555.21 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ibrance 125 mg capsules (21-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of December 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name medications, generics, vaccines, and specialized medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. This Ibrance order reflects the company's ongoing role as a critical vendor in the federal pharmaceutical supply chain, delivering oncology medications and other essential pharmaceuticals to support defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F0XV5?
SPE2DR26F0XV5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F0XV5 worth?
The government has obligated $8,555 on SPE2DR26F0XV5.
Is contract SPE2DR26F0XV5 an order under another contract?
Yes. SPE2DR26F0XV5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0XV5 competed?
The extent of competition for SPE2DR26F0XV5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award